Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Somatostatin receptor | Starlite/ChEMBL | References |
Homo sapiens | somatostatin receptor 4 | Starlite/ChEMBL | References |
Homo sapiens | somatostatin receptor 1 | Starlite/ChEMBL | References |
Homo sapiens | somatostatin receptor 5 | Starlite/ChEMBL | References |
Homo sapiens | somatostatin receptor 3 | Starlite/ChEMBL | References |
Homo sapiens | somatostatin receptor 2 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | neuropeptide receptor | Somatostatin receptor | 363 aa | 344 aa | 28.8 % |
Echinococcus granulosus | allatostatin A receptor | Somatostatin receptor | 363 aa | 301 aa | 31.6 % |
Onchocerca volvulus | Somatostatin receptor | 363 aa | 316 aa | 21.5 % | |
Onchocerca volvulus | E3 ubiquitin-protein ligase rpm-1 homolog | Somatostatin receptor | 363 aa | 347 aa | 22.5 % |
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | somatostatin receptor 4 | 388 aa | 372 aa | 20.7 % |
Onchocerca volvulus | Phospholipase d-related homolog | Somatostatin receptor | 363 aa | 295 aa | 21.0 % |
Loa Loa (eye worm) | neuropeptide F receptor | Somatostatin receptor | 363 aa | 300 aa | 26.7 % |
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | somatostatin receptor 5 | 364 aa | 392 aa | 19.4 % |
Echinococcus multilocularis | thyrotropin releasing hormone receptor | Somatostatin receptor | 363 aa | 330 aa | 27.3 % |
Onchocerca volvulus | Somatostatin receptor | 363 aa | 313 aa | 24.0 % | |
Schistosoma mansoni | adenoreceptor | Somatostatin receptor | 363 aa | 306 aa | 26.5 % |
Loa Loa (eye worm) | hypothetical protein | Somatostatin receptor | 363 aa | 291 aa | 25.4 % |
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | somatostatin receptor 2 | 369 aa | 411 aa | 18.7 % |
Onchocerca volvulus | Somatostatin receptor | 363 aa | 331 aa | 25.1 % | |
Echinococcus multilocularis | allatostatin A receptor | Somatostatin receptor | 363 aa | 306 aa | 31.7 % |
Onchocerca volvulus | Somatostatin receptor | 363 aa | 325 aa | 23.4 % | |
Schistosoma mansoni | peptide (allatostatin)-like receptor | Somatostatin receptor | 363 aa | 297 aa | 27.9 % |
Echinococcus granulosus | pyroglutamylated rfamide peptide receptor | somatostatin receptor 1 | 391 aa | 368 aa | 21.5 % |
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Somatostatin receptor | 363 aa | 292 aa | 27.4 % |
Schistosoma japonicum | ko:K04134 cholinergic receptor, invertebrate, putative | Somatostatin receptor | 363 aa | 314 aa | 23.9 % |
Echinococcus granulosus | thyrotropin releasing hormone receptor | Somatostatin receptor | 363 aa | 330 aa | 27.0 % |
Onchocerca volvulus | Somatostatin receptor | 363 aa | 318 aa | 25.2 % | |
Brugia malayi | GnHR receptor homolog | Somatostatin receptor | 363 aa | 352 aa | 21.3 % |
Echinococcus multilocularis | g protein coupled receptor | Somatostatin receptor | 363 aa | 387 aa | 21.2 % |
Schistosoma mansoni | neuropeptide F-like receptor | Somatostatin receptor | 363 aa | 295 aa | 24.1 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.052 | 0.1191 | 0.1191 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.0561 | 0.1467 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0453 | 0.0743 | 0.0743 |
Plasmodium vivax | unspecified product | 0.0561 | 0.1467 | 1 |
Loa Loa (eye worm) | low-density lipoprotein receptor repeat class B containing protein | 0.052 | 0.1191 | 0.1191 |
Echinococcus granulosus | enteropeptidase | 0.0418 | 0.0512 | 0.3488 |
Entamoeba histolytica | casein kinase, putative | 0.0561 | 0.1467 | 0.5 |
Echinococcus granulosus | laminin | 0.052 | 0.1191 | 0.8117 |
Echinococcus multilocularis | fibrillin 1 | 0.052 | 0.1191 | 0.8117 |
Loa Loa (eye worm) | hypothetical protein | 0.052 | 0.1191 | 0.1191 |
Loa Loa (eye worm) | multiple epidermal growth factor-like domains 6 | 0.052 | 0.1191 | 0.1191 |
Echinococcus multilocularis | enteropeptidase | 0.0418 | 0.0512 | 0.3488 |
Echinococcus granulosus | glycoprotein Antigen 5 | 0.0418 | 0.0512 | 0.3488 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0561 | 0.1467 | 0.5 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.0561 | 0.1467 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1837 | 1 | 1 |
Brugia malayi | acyl-CoA desaturase | 0.0381 | 0.0259 | 0.0259 |
Toxoplasma gondii | PAN domain-containing protein | 0.1534 | 0.7975 | 1 |
Loa Loa (eye worm) | acyl-CoA desaturase | 0.0381 | 0.0259 | 0.0259 |
Leishmania major | hypothetical protein, conserved | 0.0453 | 0.0743 | 0.2638 |
Schistosoma mansoni | protein kinase | 0.0561 | 0.1467 | 0.1467 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0561 | 0.1467 | 0.5 |
Trypanosoma cruzi | casein kinase II, putative | 0.0561 | 0.1467 | 1 |
Brugia malayi | Low-density lipoprotein receptor repeat class B containing protein | 0.052 | 0.1191 | 0.1191 |
Onchocerca volvulus | 0.0414 | 0.0484 | 0.0484 | |
Trichomonas vaginalis | CMGC family protein kinase | 0.0561 | 0.1467 | 0.5 |
Onchocerca volvulus | 0.0453 | 0.0743 | 0.0743 | |
Toxoplasma gondii | PAN domain-containing protein | 0.1534 | 0.7975 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0564 | 0.1483 | 0.1483 |
Echinococcus multilocularis | Mastin | 0.0418 | 0.0512 | 0.3488 |
Leishmania major | casein kinase II, putative | 0.0561 | 0.1467 | 1 |
Schistosoma mansoni | egf-like domain protein | 0.052 | 0.1191 | 0.1191 |
Echinococcus multilocularis | laminin | 0.052 | 0.1191 | 0.8117 |
Loa Loa (eye worm) | bone morphogenetic protein 1b | 0.052 | 0.1191 | 0.1191 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.0561 | 0.1467 | 0.1467 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0453 | 0.0743 | 0.0743 |
Onchocerca volvulus | 0.1837 | 1 | 1 | |
Trichomonas vaginalis | CMGC family protein kinase | 0.0561 | 0.1467 | 0.5 |
Onchocerca volvulus | Arrow homolog | 0.052 | 0.1191 | 0.1191 |
Brugia malayi | Casein kinase II, alpha chain | 0.0561 | 0.1467 | 0.1467 |
Mycobacterium ulcerans | hypothetical protein | 0.0342 | 0 | 0.5 |
Trypanosoma cruzi | fatty acid desaturase, putative | 0.0414 | 0.0484 | 0.1858 |
Giardia lamblia | Kinase, CMGC CK2 | 0.0561 | 0.1467 | 0.5 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0561 | 0.1467 | 0.5 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.0561 | 0.1467 | 0.1001 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.052 | 0.1191 | 0.0619 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.0561 | 0.1467 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0561 | 0.1467 | 0.5 |
Schistosoma mansoni | subfamily M12A unassigned peptidase (M12 family) | 0.052 | 0.1191 | 0.1191 |
Trypanosoma brucei | Casein kinase II | 0.0561 | 0.1467 | 1 |
Brugia malayi | Fibulin-1 precursor | 0.052 | 0.1191 | 0.1191 |
Loa Loa (eye worm) | hypothetical protein | 0.052 | 0.1191 | 0.1191 |
Onchocerca volvulus | 0.1495 | 0.7712 | 0.7712 | |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0453 | 0.0743 | 0.4005 |
Echinococcus granulosus | Tolloid protein 1 | 0.052 | 0.1191 | 0.8117 |
Echinococcus multilocularis | Tolloid protein 1 | 0.052 | 0.1191 | 0.8117 |
Echinococcus multilocularis | glycoprotein Antigen 5 | 0.0418 | 0.0512 | 0.3488 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0561 | 0.1467 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.1837 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0453 | 0.0743 | 0.4005 |
Loa Loa (eye worm) | hypothetical protein | 0.052 | 0.1191 | 0.1191 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0453 | 0.0743 | 0.5066 |
Brugia malayi | Calcium binding EGF domain containing protein | 0.052 | 0.1191 | 0.1191 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.1837 | 1 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0418 | 0.0512 | 0.0512 |
Onchocerca volvulus | 0.0414 | 0.0484 | 0.0484 | |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0453 | 0.0743 | 0.4005 |
Toxoplasma gondii | calcium binding egf domain-containing protein | 0.052 | 0.1191 | 0.0619 |
Brugia malayi | Kringle domain containing protein | 0.0453 | 0.0743 | 0.0743 |
Brugia malayi | Protein kinase domain containing protein | 0.0453 | 0.0743 | 0.0743 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0561 | 0.1467 | 0.5 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0453 | 0.0743 | 0.5066 |
Schistosoma mansoni | hypothetical protein | 0.0453 | 0.0743 | 0.0743 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.0561 | 0.1467 | 1 |
Echinococcus granulosus | Mastin | 0.0418 | 0.0512 | 0.3488 |
Loa Loa (eye worm) | hypothetical protein | 0.1837 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 32 nM | Antagonism of in vitro SRIF inhibition of GH release in rat in vitro pituitary cell assay | ChEMBL. | 10354394 |
Ki (binding) | = 84 nM | The compound was tested for binding affinity against human Somatostatin receptor type 2 | ChEMBL. | 10354394 |
Ki (binding) | = 210 nM | The compound was tested for binding affinity against human Somatostatin receptor type 3 | ChEMBL. | 10354394 |
Ki (binding) | > 1000 nM | The compound was tested for binding affinity against human Somatostatin receptor type 1 | ChEMBL. | 10354394 |
Ki (binding) | > 1000 nM | The compound was tested for binding affinity against human Somatostatin receptor type 4 | ChEMBL. | 10354394 |
Ki (binding) | = 2250 nM | The compound was tested for binding affinity against human Somatostatin receptor type 5 | ChEMBL. | 10354394 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.